FIELD: pharmaceuticals.
SUBSTANCE: group of inventions relates to a pharmaceutical composition and use thereof for treating gastrointestinal cancer, lung cancer and breast cancer, as well as a pharmaceutical composition preparation method. Composition comprises (R,E)-N-(4-(3-chloro-4-(pyridin-2-ylmethoxy)phenylamino)-3-cyano-7-ethoxyquinolin-6-yl)-3-(1-methylpyrrolidin-2-yl)propenamide or its pharmacologically acceptable salt, cross-linked polyvinylpyrrolidone, lactose and microcrystalline cellulose as filler, polyvinylpyrrolidone as binder, magnesium stearate as lubricant in certain amounts. Method of preparing a pharmaceutical composition comprises a step of mixing (R,E)-N-(4-(3-chloro-4-(pyridin-2-ylmethoxy)phenylamino)-3-cyano-7-ethoxyquinolin-6-yl)-3-(1-methylpyrrolidin-2-yl)propene-amide or its pharmacologically acceptable salt and cross-linked polyvinylpyrrolidone.
EFFECT: group of inventions provides a fast dissolving pharmaceutical composition for treating cancer.
6 cl, 9 dwg, 3 tbl, 17 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREPARING A PHARMACEUTICAL COMPOSITION COMPRISING A QUINOLINE DERIVATIVE OR SALT THEREOF | 2017 |
|
RU2735807C2 |
CRYSTALLINE FORM I OF TYROSINE KINASE INHIBITOR DICALETAT AND METHOD FOR ITS PREPARATION | 2013 |
|
RU2631321C2 |
CYANOQUINOLINE DERIVATIVES | 2011 |
|
RU2600928C2 |
PHARMACEUTIC COMPOSITION CONTAINING OMAGACARBOXYARYL-SUBSTITUTED DIPHENYL UREA FOR CANCER TREATMENT | 2006 |
|
RU2420283C2 |
COMBINATION OF 6-OXO-1,6-DIHYDRO-PYRIDAZINE DERIVATIVE HAVING ANTICOLIC ACTIVITY, WITH MEK INHIBITOR | 2013 |
|
RU2684407C2 |
PHARMACEUTICAL ORAL DOSAGE FORM Q203 | 2020 |
|
RU2829142C1 |
DERIVATIVES OF 1-(3-AMINOPHENYL)-6,8-DIMETHYL-5-(4-IODO-2-FLUORO-PHENYLAMINO)-3-CYCLOPROPYL-1H,6H-PYRIDO[4,3-d]PYRIMIDINE-2,4,7-TRIONE AS MEK1/2 INHIBITORS | 2015 |
|
RU2605400C1 |
CEFUROXIMAXETIL-CONTAINING COMBINATIONS | 1999 |
|
RU2248794C2 |
SUBSTITUTED 3-CYANOQUINOLINES | 1998 |
|
RU2202551C2 |
PHARMACEUTICAL PREPARATION FOR ORAL USE BASED ON RALOXYPHENE OR ITS DERIVATIVES | 1995 |
|
RU2118540C1 |
Authors
Dates
2021-02-12—Published
2017-01-23—Filed